The sociodemographic characteristics and risk factors for tuberculosis morbidity between two decades at the beginning of the 21st century at the north of Kosovo, Serbia
Abstract
Background/Aim. Tuberculosis (TB) is a major cause of mortality and morbidity worldwide, affecting different countries disproportionally. Effective diagnosis and treatment of TB saved an estimated 43 million lives between 2000 and 2014. The aim of our study was to show socio-demographic influences, risk factors for the morbidity and clinical characteristics of tuberculosis among residents of northern Kosovo, Serbia, between two decades at the beginning of the 21st century. Methods. A prospective study was conducted at the Department for Pulmonology of the Clinical-health Centre, Kosovska Mitrovica, included all tuberculosis patients treated during two three-year periods, between 2000–2002 and 2012–2014. In total, 134 patients with tuberculosis were treated, 91 in the first observed period and 43 in the second period. Results. In both observed periods, male patients suffered from tuberculosis more frequently. In the first observed period, younger and middle age (18–49) persons suffered from tuberculosis more frequently (p = 0.014). In relation to the place of residence, in the first reporting period there were more patients from urban areas, while in the second, there were significantly more patients from rural areas (p = 0.008). In the second observed period, TB was significantly more associated with chronic obstructive pulmonary disease (p = 0.001) and comorbidities with TB were significantly more frequent (p = 0.006). During the 2000–2002 period, there were more severe clinical forms, with severe radiological changes, bilateral parenchymal and cavernous forms (p = 0.08). Mild unilateral parenchymal lesions were more common in the last 3 years (p = 0.02). Conclusion. Social determinants, older age and comorbidities are the most important risk factors for the persistent number of patients, and therefore this target group needs attention during active approach in TB screening.
References
References
World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. (WHO/HTM/TB/2015).
World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization. 2013. (WHO/HTM/TB/2013.11).
Institute of Public Health of Serbia “Dr Milan Jovanović Ba-tut”. The Report on the Infectious Diseases in the Republic of Serbia for 2014. Belgrade: Institute of Public Health of Serbia “Dr Milan Jovanović Batut”; 2015.
Kurhasani X, Hafizi H, Toci E, Burazeri G. Tuberculosis Inci-dence and Case Notification Rates in Kosovo and the Balkans in 2012: Cross-country Comparison. Mater Sociomed 2014; 26(1): 55–8.
Rysstad OG, Gallefoss F. TB status among Kosovar refugees. Int J Tuberc Lung Dis 2013; 7(5): 458 ̶ 63.
Smith J, Tyrrell WF. Pulmonary tuberculosis in North Glasgow; an epidemiological study. Br Med J 1956; 2(5007): 1451–5.
Davies JW. Epidemics of tuberculosis in Canada in the sixties. Can Med Assoc J 1967; 96(16): 1156–60.
Hughes EW, Ray LR. A survey of primary pulmonary tubercu-losis in West Cornwall. Thorax 1958; 13(1): 74–88.
Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults: time to take notice. Int J Infect Dis 2015; 32: 135–7.
Skodrić-Trifunović V, Rasić T, Nagorni-Obradović L, Filipović S. Analysis of patients with tuberculosis and diabetes mellitus at the Institute of Pulmonary Diseases and Tuberculosis of the Clinical Center of Serbia (2000-2002). Med Pregl 2004; 57(Suppl 1): 59–63. (Serbian)
Dhanaraj B, Papanna MK, Adinarayanan S, Vedachalam C, Sunda-ram V, Shanmugam S, et al. Prevalence and Risk Factors for Adult Pulmonary Tuberculosis in a Metropolitan City of South India. PLoS One 2015; 10(4): e0124260.
Shanmuganathan R, Shanmuganathan ID. Clinical Manifestation and Risk Factors of Tuberculosis Infection in Malaysia: Case Study of a Community Clinic. Glob J Health Sci 2015; 7(4): 110–20.
Cheng J, Wang L, Zhang H, Xia Y. Diagnostic value of symptom screening for pulmonary tuberculosis in China. PLoS One 2015; 10(5): e0127725.
Jovanovic D, Skodric-Trifunovic V, Markovic-Denic L, Stevic R, Vla-jinac H. Clinical and epidemiological evaluation of tuberculosis in Serbia, 1990-2004. Int J Tuberc Lung Dis 2007; 11(6): 647–51.
Righi E, Della Siega P, Merelli M, Castaldo N, Beltrame A, Pea F, et al. Comparison of clinical characteristics of tuberculosis be-tween two age groups at an Italian Tertiary Hospital. Infection 2015; 43(3): 361–6.
Takarinda CK, Harries AD, Nyathi B, Ngwenya M, Mutasa-Apollo T, Sandy C. Tuberculosis treatment delays and associated fac-tors within the Zimbabwe national tuberculosis programme. BMC Public Health 2015; 15:29.
Ogbera AO, Kapur A, Abdur-Razzaq H, Harries DA, Ramaiya K, Adeleye O, et al. Clinical profile of diabetes mellitus in tuberculosis. BMJ Open Diabet Res Care 2015; 3(1): e000112.
Sunnetcioglu A, Sunnetcioglu M, Binici I, Baran AI, Karahocagil MK, Saydan MR. Comparative analysis of pulmonary and extrapul-monary tuberculosis of 411 cases. Ann Clin Microbiol Antimi-crob 2015; 14: 34.
de Colombani P, Hovhannesyan A. Wolfheze Working Group on Social Determinants of TB and Drug Resistant TB . Social de-terminants and risk factors for tuberculosis in national surveil-lance systems in Europe. Public Health Action 2015; 5(3): 194–201.
Babamahmoodi F, Alikhani A, Yazdani Charati J, Ghovvati A, Ahangarkani F, Delavarian L, et al. Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran. Biomed Res Int 2015; 2015: 381572.
Itogo N, Hill PC, Bissell K, Harries AD, Viney K, Gounder S. Tu-berculosis notifications, characteristics and treatment out-comes: Urban vs. rural Solomon Islands, 2000–2011. Public Health Action 2014; 4(Suppl 1): S25–8.
Munn MS, Duchin JS, Kay M, Pecha M, Thibault SC, Narita M. Analysis of risk factors for tuberculous infection following ex-posure at a homeless shelter. Int J Tuberc Lung Dis 2015; 19(5): 570–5.
Kowada A. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke. Int J Tuberc Lung Dis 2015; 19(7): 857–63.
Feng Y, Kong Y, Barnes PF, Huang FF, Klucar P, Wang X, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell re-sponse to influenza virus and Mycobacterium tuberculosis. In-fect Immun 2011; 79(1): 229–37.
Kirenga BJ, Ssengooba W, Muwonge C, Nakiyingi L, Kyaligonza S, Kasozi S, et al. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: Implications for tuberculosis control. BMC Public Health 2015; 15: 13.
Jurcev-Savicevic A, Mulic R, Ban B, Kozul K, Bacun-Ivcek L, Valic J, et al. Risk factors for pulmonary tuberculosis in Croatia: a matched case-control study. BMC Public Health 2013; 13: 991.
Basu S, Stuckler D, Bitton A. Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis. BMJ 2011; 343: d5506.
Przybylski G, Dąbrowska A, Trzcińska H. Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment: data from ten years' observation at the Regional Centre of Pulmonology, Byd-goszcz, Poland. Med Sci Monit 2014; 20: 444–53.
Szabo G. Alcohol's Contribution to Compromised Immunity. Alcohol Health Res World 1997; 21(1): 30–41.
Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis: a systematic review. BMC Public Health 2008; 8: 289.
Przybylski G, Nowakowska-Arendt A, Pilaczyńska-Cemel M, Gołda R. 10 years comparative clinico-epidemiological analysis of smoking and alcohol consumption in TB patients (Myc.Tuberculosis) and with mycobacteriosis (Myc. Kansas). Przegl Lek 2014; 71(11): 576–80. (Polish)
Alo A, Gounder S, Graham M. Clinical characteristics and treatment outcomes of tuberculosis cases hospitalised in the intensive phase in Fiji. Public Health Action 2014; 4(3): 164–8.
Harries AD, Satyanarayana S, Kumar AM, Nagaraja SB, Isa-akidis P, Malhotra S, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action 2013; 3(Suppl 1): S3–9.
Kwon YS, Chi YS, Oh IJ, Kim KS, Kim YI, Ch LS, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: A case control study. BMC Infect Dis 2013; 13: 121.
Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tuk-vadze L, et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgi. Int J Tuberc Lung Dis 2015; 19(6): 685–92.
Gomes T, Reis-Santos B, Bertolde A, Johnson JL, Riley LW, Macie EL. Epidemiology of extrapulmonary tuberculosis in Brazil: A hierarchical model. BMC Infect Dis 2014; 14: 9.